IBRAHIM ALAHMAD: Open Payments
NPI 1467828202 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 15 payments from 7 companies in 2025. Trend: 2023 $390 · 2024 $100 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| ABBVIE INC. | 2 | $41 |
| Insulet Corporation | 2 | $35 |
| Alkermes, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, AIRSUPRA, Omnipod, VIVITROL, QULIPTA, VRAYLAR, Cologuard Collection Kit, BREZTRI.
Industry payments across MO — which companies pay providers there.
